Access the full text.
Sign up today, get DeepDyve free for 14 days.
Journal of Advancement in Medicine Volume 12, Number 2, Summer 1999 Editorial: Effects of an Oral Vitamin B12 on HIV Affected Individuals The paper by Brennan and associates requires comment. They report a study of an uncontrolled trial of an orally active preparation con- taining B12 in the symptomatic treatment of HIV affected individ- uals. Only 10 subjects completed the study and the results were ob- tained by patient questionnaires. Eight subjects were already taking a multivitamin that contained B12 and, in addition four of them were receiving B12 in another form, by intramuscular injection in three and in tablet form in one. On the face of it, the study might be considered to be unpublishable since the confounding factors are so obvious, but there are some re- deeming features that make it worth bringing to the attention of practicing physicians. This is strictly an "Outcomes" study, perhaps the methodology that is gradually going to replace the cumbersome and potentially fallacious double blind controlled study that has long been the "gold standard" of clinical research. Admittedly, no attempt was made to give the results statistical validity, but the small num- ber of subjects precludes that and rather it should
Journal of Advancement in Medicine – Springer Journals
Published: Sep 30, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.